Bruce Waslick to Humans
This is a "connection" page, showing publications Bruce Waslick has written about Humans.
Connection Strength
0.117
-
Ignaszewski MJ, Waslick B. Update on Randomized Placebo-Controlled Trials in the Past Decade for Treatment of Major Depressive Disorder in Child and Adolescent Patients: A Systematic Review. J Child Adolesc Psychopharmacol. 2018 12; 28(10):668-675.
Score: 0.024
-
Waslick B. Benefits and harms of pediatric antidepressant medications. JAMA. 2007 Aug 08; 298(6):626; author reply 627.
Score: 0.011
-
Waslick B. Oxcarbazepine and pediatric bipolar disorder. Am J Psychiatry. 2006 Dec; 163(12):2195; author reply 2196.
Score: 0.011
-
Waslick B. Psychopharmacology interventions for pediatric anxiety disorders: a research update. Child Adolesc Psychiatr Clin N Am. 2006 Jan; 15(1):51-71.
Score: 0.010
-
Olfson M, Gameroff MJ, Marcus SC, Waslick BD. Outpatient treatment of child and adolescent depression in the United States. Arch Gen Psychiatry. 2003 Dec; 60(12):1236-42.
Score: 0.009
-
Waslick BD, Walsh BT, Greenhill LL, Eilenberg M, Capasso L, Lieber D. Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression. J Affect Disord. 1999 Dec; 56(2-3):227-36.
Score: 0.007
-
Waslick BD, Walsh BT, Greenhill LL, Giardina EG, Sloan RP, Bigger JT, Bilich K. Cardiovascular effects of desipramine in children and adults during exercise testing. J Am Acad Child Adolesc Psychiatry. 1999 Feb; 38(2):179-86.
Score: 0.006
-
Greenhill LL, Waslick B. Management of suicidal behavior in children and adolescents. Psychiatr Clin North Am. 1997 Sep; 20(3):641-66.
Score: 0.006
-
Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, Sherrill JT, Shen S, Kendall PC, McCracken J, Albano AM, Piacentini J, Riddle MA, Keeton C, Waslick B, Chrisman A, Iyengar S, March JS, Birmaher B. Child/Adolescent anxiety multimodal study: evaluating?safety. J Am Acad Child Adolesc Psychiatry. 2015 Mar; 54(3):180-90.
Score: 0.005
-
Piacentini J, Bennett S, Compton SN, Kendall PC, Birmaher B, Albano AM, March J, Sherrill J, Sakolsky D, Ginsburg G, Rynn M, Bergman RL, Gosch E, Waslick B, Iyengar S, McCracken J, Walkup J. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). J Am Acad Child Adolesc Psychiatry. 2014 Mar; 53(3):297-310.
Score: 0.004
-
March J, Silva S, Curry J, Wells K, Fairbank J, Burns B, Domino M, Vitiello B, Severe J, Riedal K, Goldman M, Feeny N, Findling R, Stull S, Baab S, Weller EB, Robbins M, Weller RA, Jessani N, Waslick B, Sweeney M, Dublin R, Walkup J, Ginsburg G, Kastelic E, Koo H, Kratochvil C, May D, LaGrone R, Vaughan B, Albano AM, Hirsch GS, Podniesinki E, Chu A, Reincecke M, Leventhal B, Rogers G, Jacobs R, Pathak S, Wells J, Lavanier SA, Danielyan A, Rohde P, Simons A, Grimm J, Frank S, Emslie G, Kennard B, Hughes C, Mayes TL, Rosenberg D, Benazon N, Butkus M, Bartoi M. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry. 2009 Oct; 166(10):1141-9.
Score: 0.003
-
Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, Ginsburg GS, Rynn MA, McCracken J, Waslick B, Iyengar S, March JS, Kendall PC. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008 Dec 25; 359(26):2753-66.
Score: 0.003
-
Vitiello B, Kratochvil CJ, Silva S, Curry J, Reinecke M, Pathak S, Waslick B, Hughes CW, Prentice ED, May DE, March JS. Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2007 Dec; 46(12):1642-50.
Score: 0.003
-
Emslie GJ, Waslick B, Weller EB, Kloos A, Weller RA, Kratochvil CJ. Antidepressant management in the context of suicidal ideation. J Am Acad Child Adolesc Psychiatry. 2007 Sep; 46(9):1222-1225.
Score: 0.003
-
Vitiello B, Rohde P, Silva S, Wells K, Casat C, Waslick B, Simons A, Reinecke M, Weller E, Kratochvil C, Walkup J, Pathak S, Robins M, March J. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006 Dec; 45(12):1419-26.
Score: 0.003
-
Emslie G, Kratochvil C, Vitiello B, Silva S, Mayes T, McNulty S, Weller E, Waslick B, Casat C, Walkup J, Pathak S, Rohde P, Posner K, March J. Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry. 2006 Dec; 45(12):1440-55.
Score: 0.003
-
Bolfek A, Jankowski JJ, Waslick B, Summergrad P. Adolescent psychopharmacology: drugs for mood disorders. Adolesc Med Clin. 2006 Oct; 17(3):789-808; abstract xiii-xiv.
Score: 0.003
-
Kratochvil CJ, Vitiello B, Walkup J, Emslie G, Waslick BD, Weller EB, Burke WJ, March JS. Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable? J Child Adolesc Psychopharmacol. 2006 Feb-Apr; 16(1-2):11-24.
Score: 0.003
-
Walsh BT, Greenhill LL, Giardina EG, Bigger JT, Waslick BD, Sloan RP, Bilich K, Wolk S, Bagiella E. Effects of desipramine on autonomic input to the heart. J Am Acad Child Adolesc Psychiatry. 1999 Sep; 38(9):1186-92.
Score: 0.002
-
Wigal SB, Swanson JM, Greenhill L, Waslick B, Cantwell D, Clevenger W, Davies M, Lerner M, Regino R, Fineberg E, Baren M, Browne R. Evaluation of individual subjects in the analog classroom setting: II. Effects of dose of amphetamine (Adderall). Psychopharmacol Bull. 1998; 34(4):833-8.
Score: 0.001